Anika Therapeutics (ANIK) Deferred Taxes (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Deferred Taxes of $129000.0 for Q2 2026, up 4400.0% year-over-year from $2866.7 in Q2 2025, and up 19.44% quarter-over-quarter from $108000.0 in Q1 2026.
Anika Therapeutics (ANIK) Deferred Taxes (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Deferred Taxes for 16 consecutive years, with $129000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Deferred Taxes rose 4400.0% year-over-year to $129000.0; the TTM figure through Jun 2026 stood at $215000.0 (up 230.77% YoY), while the FY2025 annual figure was -$7000.0, down 102.69% from the prior year.
- Deferred Taxes rose to $129000.0 in Q2 2026 per ANIK's latest filing, from $108000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $234000.0 in Q4 2024 and bottomed at -$2.4 million in Q1 2023.
- Historically, Deferred Taxes has averaged -$617055.6 across 5 years, with a median of -$104500.0 in 2024.
- Annual changes were most pronounced in 2023 — Deferred Taxes plunged 769.23% — and 2026, when it soared 4400.0%.
- Anika Therapeutics' Deferred Taxes stood at -$1.8 million in 2022, then fell by 3.6% to -$1.8 million in 2023, then surged by 112.7% to $234000.0 in 2024, then plunged by 110.68% to -$25000.0 in 2025, then jumped by 616.0% to $129000.0 in 2026.
- Business Quant data shows ANIK's Deferred Taxes at $129000.0 in Q2 2026, $108000.0 in Q1 2026, and -$25000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Anika Therapeutics | 284.33 Mn | 245.92 Mn | 21.24 Mn | 129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 129,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | -184,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | -1.84 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | -904,000.00 |
| Mar 31, 2023 | -2.37 Mn |
| Dec 31, 2022 | -1.78 Mn |
| Sep 30, 2022 | -1.47 Mn |
| Jun 30, 2022 | -1.75 Mn |
| Mar 31, 2022 | -273,000.00 |
| Dec 31, 2021 | -2.78 Mn |
| Sep 30, 2021 | -178,000.00 |